| Reference |
|---|
Arnold K, Peterson L, Beck L, Brewer M. JAK Signaling Is Critically Important in Cytokine-Induced Viral Susceptibility of Keratinocytes. Int J Mol Sci. 2023;24: pubmed publisher |
Mavrikaki M, Lee J, Solomon I, Slack F. Severe COVID-19 is associated with molecular signatures of aging in the human brain. Nat Aging. 2022;2:1130-1137 pubmed publisher |
Tsai M, Osman W, Adair J, ElMergawy R, Chafin L, Johns F, et al. The E3 ligase subunit FBXO45 binds the interferon-λ receptor and promotes its degradation during influenza virus infection. J Biol Chem. 2022;298:102698 pubmed publisher |
Hogg S, Motorna O, Kearney C, Derrick E, House I, Todorovski I, et al. Distinct modulation of IFNγ-induced transcription by BET bromodomain and catalytic P300/CBP inhibition in breast cancer. Clin Epigenetics. 2022;14:96 pubmed publisher |
Yamaguchi Y, Gibson J, Ou K, Lopez L, Ng R, Leggett N, et al. PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophages. J Immunother Cancer. 2022;10: pubmed publisher |
Baleeiro R, Bouwens C, Liu P, DI Gioia C, Dunmall L, Nagano A, et al. MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapy. Oncoimmunology. 2022;11:2080329 pubmed publisher |
Taniguchi H, Caeser R, Chavan S, Zhan Y, Chow A, Manoj P, et al. WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC. Cell Rep. 2022;39:110814 pubmed publisher |
Guo Q, Malloy M, Roweth H, McAllister S, Italiano J, Battinelli E. Platelets upregulate tumor cell programmed death ligand 1 in an epidermal growth factor receptor-dependent manner in vitro. Blood Adv. 2022;6:5668-5675 pubmed publisher |
Shikama Y, Kurosawa M, Furukawa M, Kudo Y, Ishimaru N, Matsushita K. The Priming Potential of Interferon Lambda-1 for Antiviral Defense in the Oral Mucosa. Inflammation. 2022;: pubmed publisher |
Miyamoto T, Murakami R, Hamanishi J, Tanigaki K, Hosoe Y, Mise N, et al. B7-H3 Suppresses Antitumor Immunity via the CCL2-CCR2-M2 Macrophage Axis and Contributes to Ovarian Cancer Progression. Cancer Immunol Res. 2022;10:56-69 pubmed publisher |
Zhang Z, Yang A, Chaurasiya S, Park A, Lu J, Kim S, et al. CF33-hNIS-antiPDL1 virus primes pancreatic ductal adenocarcinoma for enhanced anti-PD-L1 therapy. Cancer Gene Ther. 2022;29:722-733 pubmed publisher |
Rafieerad A, Yan W, Alagarsamy K, Srivastava A, Sareen N, Arora R, et al. Fabrication of Smart Tantalum Carbide MXene Quantum Dots with Intrinsic Immunomodulatory Properties for Treatment of Allograft Vasculopathy. Adv Funct Mater. 2021;31:2106786 pubmed publisher |
Chen B, Scurrah C, McKinley E, Simmons A, Ramirez Solano M, Zhu X, et al. Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps. Cell. 2021;184:6262-6280.e26 pubmed publisher |
Zhang C, Chinnappan M, Prestwood C, Edwards M, Artami M, Thompson B, et al. Interleukins 4 and 13 drive lipid abnormalities in skin cells through regulation of sex steroid hormone synthesis. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher |
Jiang Z, Lim S, Yan M, Hsu J, Yao J, Wei Y, et al. TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis. J Clin Invest. 2021;131: pubmed publisher |
Sharma V, Pope B, Santiago N, Boland M, Sun D, Reynolds R, et al. Decreased Levels of STAT1 and Interferon-γ-Induced STAT1 Phosphorylation in Rheumatoid Arthritis CD4 and CD8 T Cells. ACR Open Rheumatol. 2021;3:277-283 pubmed publisher |
Stringhini M, Mock J, Fontana V, Murer P, Neri D. Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression. MAbs. 2021;13:1868066 pubmed publisher |
Becker W, Alrafas H, Busbee P, Walla M, Wilson K, Miranda K, et al. Cannabinoid Receptor Activation on Haematopoietic Cells and Enterocytes Protects against Colitis. J Crohns Colitis. 2021;15:1032-1048 pubmed publisher |
Stebbing J, Sánchez Nievas G, Falcone M, Youhanna S, Richardson P, Ottaviani S, et al. JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality. Sci Adv. 2021;7: pubmed publisher |
Wrenn E, Yamamoto A, Moore B, Huang Y, McBirney M, Thomas A, et al. Regulation of Collective Metastasis by Nanolumenal Signaling. Cell. 2020;183:395-410.e19 pubmed publisher |
Lin H, Ji D, Lucherelli M, Reina G, Ippolito S, Samor xec P, et al. Comparative Effects of Graphene and Molybdenum Disulfide on Human Macrophage Toxicity. Small. 2020;16:e2002194 pubmed publisher |
Nenasheva T, Gerasimova T, Serdyuk Y, Grigor eva E, Kosmiadi G, Nikolaev A, et al. Macrophages Derived From Human Induced Pluripotent Stem Cells Are Low-Activated "Naïve-Like" Cells Capable of Restricting Mycobacteria Growth. Front Immunol. 2020;11:1016 pubmed publisher |
Brasil da Costa F, Lewis M, Truong A, Carson D, Farach Carson M. SULF1 suppresses Wnt3A-driven growth of bone metastatic prostate cancer in perlecan-modified 3D cancer-stroma-macrophage triculture models. PLoS ONE. 2020;15:e0230354 pubmed publisher |
Zhang H, Wang Y, Wang Q, Sun S, Li S, Shang H, et al. Enhanced Human T Lymphocyte Antigen Priming by Cytokine-Matured Dendritic Cells Overexpressing Bcl-2 and IL-12. Front Cell Dev Biol. 2020;8:205 pubmed publisher |
Gruber C, Martín Fernandez M, Ailal F, Qiu X, Taft J, Altman J, et al. Homozygous STAT2 gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy. J Exp Med. 2020;217: pubmed publisher |
Rajan S, Amin A, Li L, Rolland D, Li H, Kwon D, et al. The mechanism of cancer drug addiction in ALK-positive T-Cell lymphoma. Oncogene. 2020;39:2103-2117 pubmed publisher |
Gilad Y, Eliaz Y, Yu Y, Han S, O Malley B, Lonard D. Drug-induced PD-L1 expression and cell stress response in breast cancer cells can be balanced by drug combination. Sci Rep. 2019;9:15099 pubmed publisher |
Nguyen D, Theodoropoulos G, Li Y, Wu C, Sha W, Feun L, et al. Targeting the Kynurenine Pathway for the Treatment of Cisplatin-Resistant Lung Cancer. Mol Cancer Res. 2020;18:105-117 pubmed publisher |
Sugawara E, Kato M, Kudo Y, Lee W, Hisada R, Fujieda Y, et al. Autophagy promotes citrullination of VIM (vimentin) and its interaction with major histocompatibility complex class II in synovial fibroblasts. Autophagy. 2020;16:946-955 pubmed publisher |
Guo J, Muse E, Christians A, Swanson S, Davila E. An Anticancer Drug Cocktail of Three Kinase Inhibitors Improved Response to a Dendritic Cell-Based Cancer Vaccine. Cancer Immunol Res. 2019;7:1523-1534 pubmed publisher |
Jenks S, Cashman K, Zumaquero E, Marigorta U, Patel A, Wang X, et al. Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus. Immunity. 2018;49:725-739.e6 pubmed publisher |
Tran L, Allen C, Xiao R, Moore E, Davis R, Park S, et al. Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma. Cancer Immunol Res. 2017;5:1141-1151 pubmed publisher |
